Role of TET1-mediated epigenetic modulation in Alzheimer's disease

Neurobiol Dis. 2023 Sep:185:106257. doi: 10.1016/j.nbd.2023.106257. Epub 2023 Aug 8.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder influenced by a complex interplay of environmental, epigenetic, and genetic factors. DNA methylation (5mC) and hydroxymethylation (5hmC) are DNA modifications that serve as tissue-specific and temporal regulators of gene expression. TET family enzymes dynamically regulate these epigenetic modifications in response to environmental conditions, connecting environmental factors with gene expression. Previous epigenetic studies have identified 5mC and 5hmC changes associated with AD. In this study, we performed targeted resequencing of TET1 on a cohort of early-onset AD (EOAD) and control samples. Through gene-wise burden analysis, we observed significant enrichment of rare TET1 variants associated with AD (p = 0.04). We also profiled 5hmC in human postmortem brain tissues from AD and control groups. Our analysis identified differentially hydroxymethylated regions (DhMRs) in key genes responsible for regulating the methylome: TET3, DNMT3L, DNMT3A, and MECP2. To further investigate the role of Tet1 in AD pathogenesis, we used the 5xFAD mouse model with a Tet1 KO allele to examine how Tet1 loss influences AD pathogenesis. We observed significant changes in neuropathology, 5hmC, and RNA expression associated with Tet1 loss, while the behavioral alterations were not significant. The loss of Tet1 significantly increased amyloid plaque burden in the 5xFAD mouse (p = 0.044) and lead to a non-significant trend towards exacerbated AD-associated stress response in 5xFAD mice. At the molecular level, we found significant DhMRs enriched in genes involved in pathways responsible for neuronal projection organization, dendritic spine development and organization, and myelin assembly. RNA-Seq analysis revealed a significant increase in the expression of AD-associated genes such as Mpeg1, Ctsd, and Trem2. In conclusion, our results suggest that TET enzymes, particularly TET1, which regulate the methylome, may contribute to AD pathogenesis, as the loss of TET function increases AD-associated pathology.

Keywords: 5-hydroxymethylcytosine; Alzheimer's disease; Gene expression; Tet1 protein.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 5-Methylcytosine
  • Alzheimer Disease* / metabolism
  • Animals
  • DNA Methylation
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Epigenesis, Genetic
  • Humans
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mixed Function Oxygenases / genetics
  • Mixed Function Oxygenases / metabolism
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • Receptors, Immunologic / metabolism
  • Transcription Factors / metabolism

Substances

  • 5-Methylcytosine
  • Transcription Factors
  • TET1 protein, human
  • Mixed Function Oxygenases
  • Proto-Oncogene Proteins
  • Trem2 protein, mouse
  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TET1 protein, mouse
  • DNA-Binding Proteins